Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of moderate intervertebral disc degeneration with autologous bone marrow-derived mesenchymal stem cells
2012-003160-44Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2013
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Provacel in degenerative disc disease (DDD) and lumbosacral spondylosis, sponsored by Aarhus University Hospital. Primary endpoint: Oswestry Disability Index. Started Jan 2013; status: completed.
02
Drugs
Provacel
03
Conditions
degenerative disc disease (DDD)lumbosacral spondylosis
Beyond the preview
Go deeper on 2012-003160-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003160-44.